2011

Welcome to Volume 10, Issue #1 (JANUARY 12, 2011) of Pharma Marketing News.

The drug industry brings legal heat to the issue of off-label drug promotion.

This article reports the results of an informal Weber Shandwick survey regarding social media guidelines recently published by the British pharmaceutical industry regulators. It includes advice for how to innovate online without waiting for more specific guidelines from regulators.

The fear is that if the first steps by pharma to engage in social media conversation are too harshly scrutinized and criticized, the drug industry will shy away from getting more involved in social media.

The Death of the Traditional Pharma Salesman and the Birth of the 'Sales Cyborg.' eDetailing in one form or another seems to be making a comeback since the recession hit the drug industry in 2007 and 2008. Which is the 'chicken' and which is the 'egg'? Did the uptick in adoption of eDetailing technology lead to the recent layoff of pharma reps or were reps laid off because of the economy and subsequently replaced by machines?

Social media occupied a good deal of our attention in 2010 and many of the pharma people Pharmaguy met and interacted with in 2010 are involved in social media campaigns in one way or another.

Public health officials cannot depend upon their noses to make important decisions. They need actionable real time data. How do they get it?

Pharma marketers save a bundle repurposing videos for Youtube. They save even more money by hiring real patients to play themselves in these videos! Patients are natural method actors, having actually experienced what they portray. But they are prone to over emote!

Welcome to Volume 10, Issue #8 (28 APRIL 2011) of Pharma Marketing News.

Looming Challenges Cloud Implementation. This article reviews the strategic implications of the Sunshine Act and also presents highlights of the draft regulations rule released by the Centers for Medicare and Medicaid Services on December 15, 2011.